Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 01 tags : Earnings save search
Revance to Release Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
VTRS | $11.2 0.72% 1M
|
Health Technology
|
| O: 0.59%
H: 1.18%
C: 0.59%
RVNC | $3.76 -0.79% 230K
|
Health Technology
|
| O: 0.85%
H: 1.73%
C: -0.18%
financial results
Intercept Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: 7.35%
H: 9.34%
C: 5.64%
pharmaceuticals financial update results
Ecolab Third Quarter Reported Diluted EPS $1.21; Adjusted Diluted EPS $1.30 With Double-Digit Growth in Sales and Pricing; Expect Continued Improvement in Fourth Quarter 2022 Performance
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
ECL | $218.43 -0.36% 240K
|
Process Industries
|
| O: -4.64%
H: 0.47%
C: -4.54%
sales growth
Chemomab Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Business Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
CMMB | News | $0.7 5.7K
|
Manufacturing
|
| O: -1.74%
H: 2.52%
C: 1.02%
report therapeutics financial update results
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.195 0.8% 1.4M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | $20.2 510
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN | News 0 d | $40.43 -4.1% 560K
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | $87.02 0.99% 140K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $24.42 0.45% 440K
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $34.04 -0.73% 86K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
WAT | $295.25 0.35% 68K
|
Health Technology
|
| O: 1.57%
H: 2.26%
C: 1.18%
BRKR | $77.97 -0.75% 400K
|
Health Technology
|
| O: 0.74%
H: 2.01%
C: 1.08%
corporation financial results
Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
PYXS | $4.37 -3.53% 130K
|
Professional, Scientific, and T...
|
| O: 1.6%
H: 0.0%
C: -11.05%
financial update
IDEXX Laboratories Announces Third Quarter 2022 Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
IDXX | $474.3 -0.73% 120K
|
Health Technology
|
| O: 4.28%
H: 6.82%
C: 5.3%
results
Axcella Reports Third Quarter Financial Results and Provides Business Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -9.43%
financial update results
Catalent, Inc. Reports First Quarter Fiscal 2023 Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
CTLT | $55.92 0.22% 250K
|
Health Technology
|
| O: -25.04%
H: 9.17%
C: 0.53%
results
Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: 48.12%
H: 0.0%
C: 0.0%
year
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.65 -1.58% 130K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | $18.0 -0.28% 33K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Neurocrine Biosciences Reports Third Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NBIX M | $131.98 -0.42% 140K
|
Health Technology
|
| O: -0.1%
H: 7.37%
C: 3.79%
sales ingrezza financial results
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HRMY | $29.19 0.55% 48K
|
Health Technology
|
| O: 5.1%
H: 8.45%
C: 8.44%
financial results
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
RGEN | $158.01 0.61% 65K
|
Health Technology
|
| O: -7.94%
H: 12.25%
C: 10.45%
year financial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.